Cellzome

CellZome is a pharmaceutical company that discovers, develops, and commercializes kinase-targeted drugs for the treatment of inflammatory diseases. It has developed a pipeline of kinase inhibitors targeting inflammatory mediators as oral therapeutic agents for rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, psoriasis, and asthma.